Register Login

Dabigatran Reversal Agent

In a report given at the International Society for Thrombosis and Haemostasis biennial meeting in Toronto, Dr. Charles Pollack indicated that a trial of the Boehringer-Ingelheim drug idarucizumab safely and effectively reversed the effects of dabigatran. To see the full report, select Dabigatran Reversal Agent RE-VERSE AD on Heartwire.

Comments (0)
Anticoagulant Therapy

No comments here.

Leave a Reply